News

April 25, 2017

SMA Community's Voice Heard “Loud and Clear” at Last Week's Patient Focused Drug Development Meeting with the FDA

SMA Community's Voice Heard “Loud and Clear” at Last Week's Patient Focused Drug Development Meeting with the FDA

On April 18, 2017, the SMA community—families, clinicians, researchers, industry and regulators—gathered for a Patient-Focused Drug Development (PFDD) Meeting with the FDA.

As part of the reauthorization of the Prescription Drug User Fee Act (PDUFA), the FDA is required to...

READ MORE   |  

Topics: Community & Awareness, Our Impact, Advocacy, Front Page News

April 21, 2017

Cure SMA to Host Webinar on Spinraza Access, as List of Administration Sites is Released

Cure SMA to Host Webinar on Spinraza Access, as List of Administration Sites is Released

On Thursday, May 4, at 1:00pm EST (10:00am PST/11:00am MST/12:00pm CST), Cure SMA will hold a webinar updating the community on the status of Spinraza access. Among the topics covered will be:

  • The current status of dosing in states across the US
  • Administration sites,...

READ MORE   |  

Topics: Community & Awareness, Front Page News

April 10, 2017

Cure SMA Publishes Second Journal Article on the Patient Voice

Cure SMA, along with collaborators from Biogen and the SMA Foundation, have published a paper in the journal BMC Neurology

In recent years, we've completed 16 focus group sessions and 37 interviews in the US with 96 participants...

READ MORE   |  

Topics: Community & Awareness, Front Page News

Items 1 - 3 of 79  12345678910Next

© 2014 Cure SMA | Privacy Policy

Powered by Blackbaud
nonprofit software